Detalles de la búsqueda
1.
10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers.
Lancet Oncol
; 19(3): 285-287, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29508745
2.
Rescuing Drugs That are Discontinued in Adult Oncology Development for the Benefit of Children and Adolescents With Cancer - An ACCELERATE Multistakeholder Consensus.
Clin Pharmacol Ther
; 115(1): 36-41, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37885401
3.
Frontline and Relapsed Rhabdomyosarcoma (FAR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
Cancers (Basel)
; 16(5)2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38473359
4.
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
; 190: 112950, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37441939
5.
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
; 160: 112-133, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34840026
6.
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
; 173: 71-90, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35863108
7.
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
; 139: 135-148, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32992153
8.
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
; 136: 116-129, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32688206
9.
Orphan Drug Regulation: A missed opportunity for children and adolescents with cancer.
Eur J Cancer
; 84: 149-158, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28818704
10.
When Innovation and Commercialization Collide: A Patient Advocate View in Neuroblastoma.
J Clin Oncol
; 40(2): 120-126, 2022 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34793201
Resultados
1 -
10
de 10
1
Próxima >
>>